is zepbound a glp-1 agonist GLP-1? Zepbound Effective for Weight Loss

Farxiga typically lowers A1C by about 0.8% through its insulin-independent mechanism

This reduction in calorie intake, and subsequent weight loss, is believed to be caused by a decrease in appetite and cravings and a reduction in cravings for high-fat foods

Postgrad Med (2019) 131(2):828

2009;32(suppl 2):S151-S156

Impacts of glucagon-like peptide-1 receptor agonists on the risk of adverse liver outcomes in patients with metabolic dysfunction-associated steatotic liver disease cirrhosis and type 2 diabetes

FDA Drug Safety Communication: FDA investigating reports of possible increased risk of pancreatitis and pre-cancerous findings of the pancreas from incretin mimetic drugs for type 2 diabetes